Result Summary for S2WB3004
| Protocol ID: | S2WB3004 |
| Clinical Study ID: | S2WB3004 |
| Official Title: | An open study of the long-term safety and efficacy of oral naratriptan 2.5mg in the acute treatment of migraine. |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | naratriptan |
| Trade/Product Name: | amerge;naramig |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
